Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory W Mattingly

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Psychiatry|March 31, 2022
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE StudyGregory W Mattingly, Hongye Ren, Michael Cronquist Christensen, et al.
Patient Preference and Adherence|May 31, 2021
Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice ExperimentM Janelle Cambron-Mellott, Jaromir Mikl, Joana E Matos, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 2024
AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential MedicinesSamuele Cortese, David Coghill, Gregory W Mattingly, et al.
JAMA Psychiatry|July 2, 2025
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical TrialAdam Janik, Xin Qiu, Rosanne Lane, et al.
Neuropsychiatric Disease and Treatment|March 20, 2025
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of SchizophreniaLeslie Citrome, Christoph U Correll, Andrew J Cutler, et al.
The Journal of Clinical Psychiatry|December 28, 2023
Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder: Interim Results From the Open-Label, Phase 3 SHORELINE StudyAndrew J Cutler, Gregory W Mattingly, Susan G Kornstein, et al.
CNS Spectrums|May 20, 2024
Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorderJennifer Hong, Gregory W Mattingly, Julie A Carbray, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Psychiatry|March 31, 2022
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE StudyGregory W Mattingly, Hongye Ren, Michael Cronquist Christensen, et al.
Patient Preference and Adherence|May 31, 2021
Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice ExperimentM Janelle Cambron-Mellott, Jaromir Mikl, Joana E Matos, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 2024
AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential MedicinesSamuele Cortese, David Coghill, Gregory W Mattingly, et al.
JAMA Psychiatry|July 2, 2025
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical TrialAdam Janik, Xin Qiu, Rosanne Lane, et al.
Neuropsychiatric Disease and Treatment|March 20, 2025
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of SchizophreniaLeslie Citrome, Christoph U Correll, Andrew J Cutler, et al.
The Journal of Clinical Psychiatry|December 28, 2023
Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder: Interim Results From the Open-Label, Phase 3 SHORELINE StudyAndrew J Cutler, Gregory W Mattingly, Susan G Kornstein, et al.
CNS Spectrums|May 20, 2024
Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorderJennifer Hong, Gregory W Mattingly, Julie A Carbray, et al.
Pageof 2